Natixis Investment Managers International’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,236
Closed -$139K 193
2018
Q3
$139K Sell
2,236
-3,260
-59% -$198K 0.01% 637
2018
Q2
$296K Buy
5,496
+1,133
+26% +$56.6K 0.02% 514
2018
Q1
$198K Buy
+4,363
New +$187K 0.01% 354
2017
Q4
Sell
-1,257
Closed -$46K 229
2017
Q3
$46K Hold
1,257
﹤0.01% 391
2017
Q2
$48K Hold
1,257
﹤0.01% 392
2017
Q1
$43K Hold
1,257
﹤0.01% 388
2016
Q4
$41K Buy
+1,257
New +$40.8K ﹤0.01% 416

Other funds holding EHC

Natixis Investment Managers International's EHC Position: Q4 2018 in Review

Natixis Investment Managers International sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 2,236 shares — an estimated $139K sold.

Natixis Investment Managers International first reported a position in EHC in Q4 2016 and held it in 7 quarters. The position peaked at $296K in Q2 2018. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

  • Natixis Investment Managers International reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 2,236 Encompass Health shares in Q4 2018, an estimated $139K.
  • Natixis Investment Managers International first reported a position in Encompass Health in Q4 2016 and held it in 7 quarters.
  • Natixis Investment Managers International's Encompass Health position peaked at $296K in Q2 2018.
  • 447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on Natixis Investment Managers International's 13F filing for Q4 2018, filed 14 Feb 2019.